Homeostasis model assessment-insulin resistance (HOMA-IR), a key role for assessing the ovulation function in polycystic ovary syndrome (PCOS) patients with insulin resistance.
According to our research, we evaluated that for the ovulation function in polycystic ovary syndrome (PCOS) with IR, Homeostasis model assessment-insulin resistance (HOMA-IR) is a clinic , simple and practical and sensitive Index for assessing the ovualtion failure. Meanwhile, after anti-IR treatment, HOMA-IR is also a reliable and simple for accessing the recoverying ovulation function.
Ma
Fang
F
Department of Histology and Embryology, West China College of Medicine, Sichuan University, Chengdu, P. R. China.
Qiao
Lin
L
Yue
Huanxun
H
Xie
Shuxiang
S
Zhou
Xue
X
Jiang
Min
M
Zhang
Wei
W
Qi
Jianguo
J
Wang
Lei
L
Xu
Kehui
K
D017373:Cyproterone Acetate / Q000627:therapeutic use; D004338:Drug Combinations; D004997:Ethinyl Estradiol / Q000627:therapeutic use; D005260:Female; D006706:Homeostasis; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007333:Insulin Resistance; D008687:Metformin / Q000627:therapeutic use; D008954:Models, Biological; D006080:Ovarian Follicle / Q000473:pathology; D010053:Ovary / Q000503:physiopathology; D010060:Ovulation; D011085:Polycystic Ovary Syndrome / Q000188:drug therapy / Q000473:pathology / Q000503:physiopathology*; D012680:Sensitivity and Specificity
D004338:Drug Combinations; D007004:Hypoglycemic Agents; D004997:Ethinyl Estradiol; D017373:Cyproterone Acetate; C032640:Cyproterone acetate, ethinyl estradiol drug combination; D008687:Metformin